Cureus · 2026
Severe Suspected Metformin-Associated Lactic Acidosis With Relatively Preserved Serum Creatinine at Presentation: Sequential Intermittent Hemodialysis and Continuous Venovenous Hemodialysis.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hassanein Mahmoud, Rodriguez Christina, Lentine Krista L
Аннотация
Metformin-associated lactic acidosis (MALA) is an uncommon but potentially fatal complication of metformin therapy in which extracorporeal treatment may be required for severe acidemia or markedly elevated lactate levels. We report the case of a 47-year-old man with type 2 diabetes mellitus treated with metformin who presented with encephalopathy, profound hypoglycemia, hypothermia, and severe high-anion-gap metabolic acidosis. Lactate was 24.1 mmol/L and peaked at 25.5 mmol/L, while serum total carbon dioxide was <5 mmol/L. Despite the severity of the metabolic disturbance, serum creatinine was 1.18 mg/dL on presentation, although he had experienced recent acute kidney injury. Toxicologic evaluation did not identify an alternative major cause of the acidosis, although urine testing was positive for amphetamine/methamphetamine, suggesting a potentially multifactorial process. The patient received supportive care and repeated intravenous sodium bicarbonate before extracorporeal treatment. Lactate had already declined from 25.5 to 16.0 mmol/L before dialysis began, while acidemia partially improved after bicarbonate administration. High-efficiency intermittent hemodialysis (iHD) was initiated for severe suspected MALA as the rapid initial phase of extracorporeal treatment, followed by continuous venovenous hemodialysis to provide sustained therapy toward biochemical treatment targets; hemodynamic intolerance during iHD further supported the transition. Lactate subsequently normalized without rebound, and kidney function recovered without further renal replacement therapy. This case highlights that severe suspected MALA may warrant extracorporeal treatment despite relatively preserved creatinine at presentation and illustrates the importance of aligning biochemical trends with treatment timing when assessing the contribution of dialysis to lactate and acid-base correction.